(1) A carrier shall report to the commissioner:
The number of in-network providers who are federally licensed to prescribe medication-assisted treatment for substance use disorders, including buprenorphine; and
The number of prescriptions filled by enrollees for medication-assisted treatment forsubstance use disorders; and
The carrier's efforts to ensure sufficient capacity for and access to medicationassisted treatment for substance use disorders.
(2) The commissioner shall promulgate rules concerning the reporting requirements specified in subsection (1) of this section, including the reporting period, the frequency of reporting, and any other provisions necessary to comply with the reporting requirement.
Source: L. 2020: Entire section added, (SB 20-007), ch. 286, p. 1391, § 9, effective July 13.